BDBM472926 (6aR)-4-(pentan-2-yl)-6,6a,7,8,9,10-hexahydro- 5H-pyrazino[1,2-a][1,8]naphthyridine::US10836764, Compound 109

SMILES CCCC(C)c1ccnc2N3CCNC[C@H]3CCc12

InChI Key InChIKey=CUCUTQPVFJILKT-ZGTCLIOFSA-N

Data  3 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 472926   

Target5-hydroxytryptamine receptor 2C(Homo sapiens (Human))
Arena Pharmaceuticals

US Patent
LigandPNGBDBM472926((6aR)-4-(pentan-2-yl)-6,6a,7,8,9,10-hexahydro- 5H-...)
Affinity DataKi:  4.45nMAssay Description:Radioligand binding assays were performed using the commercially available 5-HT2 receptor agonist [125I]DOI as the radioligand and nonspecific bindin...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Arena Pharmaceuticals

US Patent
LigandPNGBDBM472926((6aR)-4-(pentan-2-yl)-6,6a,7,8,9,10-hexahydro- 5H-...)
Affinity DataKi:  25.9nMAssay Description:Radioligand binding assays were performed using the commercially available 5-HT2 receptor agonist [125I]DOI as the radioligand and nonspecific bindin...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2B(Homo sapiens (Human))
Arena Pharmaceuticals

US Patent
LigandPNGBDBM472926((6aR)-4-(pentan-2-yl)-6,6a,7,8,9,10-hexahydro- 5H-...)
Affinity DataKi:  37.7nMAssay Description:Radioligand binding assays were performed using the commercially available 5-HT2 receptor agonist [125I]DOI as the radioligand and nonspecific bindin...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent